Citigroup’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-374
| Closed | -$1.83K | – | 4833 |
|
|
2024
Q4 | $1.83K | Hold |
374
| – | – | ﹤0.01% | 4685 |
|
|
2024
Q3 | $1.88K | Hold |
374
| – | – | ﹤0.01% | 4598 |
|
|
2024
Q2 | $1.54K | Hold |
374
| – | – | ﹤0.01% | 4575 |
|
|
2024
Q1 | $2.84K | Hold |
374
| – | – | ﹤0.01% | 4587 |
|
|
2023
Q4 | $3.12K | Hold |
374
| – | – | ﹤0.01% | 4592 |
|
|
2023
Q3 | $3.16K | Hold |
374
| – | – | ﹤0.01% | 4098 |
|
|
2023
Q2 | $3.55K | Hold |
374
| – | – | ﹤0.01% | 4494 |
|
|
2023
Q1 | $2.17K | Hold |
374
| – | – | ﹤0.01% | 4367 |
|
|
2022
Q4 | $3.04K | Hold |
374
| – | – | ﹤0.01% | 4388 |
|
|
2022
Q3 | $3K | Sell |
374
-17
| -4% | -$136 | ﹤0.01% | 4579 |
|
|
2022
Q2 | $4K | Sell |
391
-405
| -51% | -$4.14K | ﹤0.01% | 4891 |
|
|
2022
Q1 | $17K | Sell |
796
-135
| -15% | -$2.88K | ﹤0.01% | 4490 |
|
|
2021
Q4 | $27K | Buy |
931
+683
| +275% | +$19.8K | ﹤0.01% | 4536 |
|
|
2021
Q3 | $24K | Buy |
248
+220
| +786% | +$21.3K | ﹤0.01% | 4400 |
|
|
2021
Q2 | $4K | Sell |
28
-11
| -28% | -$1.57K | ﹤0.01% | 5188 |
|
|
2021
Q1 | $7K | Buy |
+39
| New | +$7K | ﹤0.01% | 5133 |
|